Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Endocrine Gland Neoplasms
Diseases [C] » Endocrine System Diseases [C19] » Endocrine Gland Neoplasms
Description
Tumors or cancer of the ENDOCRINE GLANDS. MeSH
Hierarchy View
Subtype Terms (9)
Adrenal Gland Neoplasms
38 drugs (27 approved, 11 experimental)
Multiple Endocrine Neoplasia
4 drugs (3 approved, 1 experimental)
Ovarian Neoplasms
855 drugs (251 approved, 604 experimental)
Pancreatic Neoplasms
978 drugs (296 approved, 682 experimental)
Paraneoplastic Endocrine Syndromes
Parathyroid Neoplasms
12 drugs (9 approved, 3 experimental)
Pituitary Neoplasms
43 drugs (32 approved, 11 experimental)
Testicular Neoplasms
136 drugs (91 approved, 45 experimental)
Thyroid Neoplasms
200 drugs (126 approved, 74 experimental)
Phase 3 Indicated Drugs (3)
Phase 2 Indicated Drugs (7)
Phase 1 Indicated Drugs (3)
Organization Involved with Phase 4 Indications (4)
Organization Involved with Phase 3 Indications (6)
Organization Involved with Phase 2 Indications (25)
Organization Involved with Phase 1 Indications (4)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
